FDA.reportPublic FDA data

valbenazine 40 MG Oral Capsule [Ingrezza]

RxCUI
1918230
RxNorm name
valbenazine 40 MG Oral Capsule [Ingrezza]
Display name
valbenazine 40 MG Oral Capsule [Ingrezza]
Full name
valbenazine 40 MG Oral Capsule [Ingrezza]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
INGREZZAVALBENAZINENeurocrine Biosciences, Inc.4c970164-cafb-421f-9eb5-c226ef0a34172026-04-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1918230

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4c970164-cafb-421f-9eb5-c226ef0a3417INGREZZA 40 MG Oral Capsule [PSN] · valbenazine 40 MG Oral Capsule [Ingrezza] [SBD] · Ingrezza 40 MG (as valbenazine tosylate 73 MG) Oral Capsule [SY] · Ingrezza 40 MG Oral Capsule [SY]434These highlights do not include all the information needed to use INGREZZA or INGREZZA SPRINKLE safely and effectively. See full prescribing information for INGREZZA. INGREZZA ® (valbenazine) capsules, for oral use INGREZZA ® SPRINKLE (valbenazine) capsules, for oral use Initial U.S. Approval: 201720260417